Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Score Based Radiomics in Nasopharyngeal Carcinoma (IMRAN Study)

NCT05126160 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.

NCT NCT05126160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05126160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Score Based Radiomics in Nasopharyngeal Carcinoma (IMRAN Study)
Lead sponsor
Zhejiang Cancer Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 5, 2021
Completion date
December 31, 2027
Enrollment
494 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma